Acute Kidney Injury (AKI) involves sudden kidney function loss, often from ischemia, toxins, or sepsis. Clinical trials explore biomarkers for early detection and therapies like cell-based treatments, nephroprotective drugs, and AI-driven monitoring to enhance recovery and outcomes.